October 16, 2025 — Leads & Copy — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) will host a conference call and webcast on Thursday, October 30, 2025, at 8:30 a.m. ET to discuss its third quarter 2025 financial results.
To access the live call by phone, pre-register here. A live audio webcast of the event and slides can be accessed on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A webcast replay will be available for 90 days.
Apellis Pharmaceuticals is a biopharmaceutical company focused on complement science to develop therapies for challenging diseases. They have two C3-targeting medicines approved to treat four serious diseases, including the first therapy for geographic atrophy and the first treatment for patients 12 and older with C3G or primary IC-MPGN.
Investor Contact:
Eva Stroynowski
eva.stroynowski@apellis.com
617.938.6229
Source: Apellis Pharmaceuticals, Inc.
